[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU682805B1 - Method for inducing a systemic immune response to an antigen - Google Patents

Method for inducing a systemic immune response to an antigen

Info

Publication number
AU682805B1
AU682805B1 AU70643/96A AU7064396A AU682805B1 AU 682805 B1 AU682805 B1 AU 682805B1 AU 70643/96 A AU70643/96 A AU 70643/96A AU 7064396 A AU7064396 A AU 7064396A AU 682805 B1 AU682805 B1 AU 682805B1
Authority
AU
Australia
Prior art keywords
antigen
inducing
immune response
systemic immune
systemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU70643/96A
Inventor
Darryl M. See
Jackie R. See
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSPHERE TECHNOLOGIES Inc
Original Assignee
BIO SPHERE TECHNOLOGIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO SPHERE TECHNOLOGIES Inc filed Critical BIO SPHERE TECHNOLOGIES Inc
Application granted granted Critical
Publication of AU682805B1 publication Critical patent/AU682805B1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU70643/96A 1996-03-22 1996-11-06 Method for inducing a systemic immune response to an antigen Ceased AU682805B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62180296A 1996-03-22 1996-03-22
US621802 2000-07-21

Publications (1)

Publication Number Publication Date
AU682805B1 true AU682805B1 (en) 1997-10-16

Family

ID=24491698

Family Applications (2)

Application Number Title Priority Date Filing Date
AU70643/96A Ceased AU682805B1 (en) 1996-03-22 1996-11-06 Method for inducing a systemic immune response to an antigen
AU25407/97A Abandoned AU2540797A (en) 1996-03-22 1997-03-24 Method for inducing a systemic immune response to an antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU25407/97A Abandoned AU2540797A (en) 1996-03-22 1997-03-24 Method for inducing a systemic immune response to an antigen

Country Status (3)

Country Link
EP (1) EP0932392A1 (en)
AU (2) AU682805B1 (en)
WO (1) WO1997034583A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806912B1 (en) * 2000-04-04 2004-07-23 Fond Mondiale Rech Et Preventi USE OF MODIFIED gp120 AND gp160 PROTEINS IN HIV-1 V3 LOOP FOR THE PREPARATION OF VACCINE COMPOSITIONS AND FORMULATIONS CONTAINING THEM

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145410A (en) * 1976-10-12 1979-03-20 Sears Barry D Method of preparing a controlled-release pharmaceutical preparation, and resulting composition
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
AU3575893A (en) * 1992-03-03 1993-10-05 Daiichi Pharmaceutical Co., Ltd. Oral vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208036A (en) * 1985-01-07 1993-05-04 Syntex (U.S.A.) Inc. N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
CA2117769C (en) * 1992-04-10 2003-07-22 Shuji Sato Liposome composition
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145410A (en) * 1976-10-12 1979-03-20 Sears Barry D Method of preparing a controlled-release pharmaceutical preparation, and resulting composition
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
AU3575893A (en) * 1992-03-03 1993-10-05 Daiichi Pharmaceutical Co., Ltd. Oral vaccine

Also Published As

Publication number Publication date
AU2540797A (en) 1997-10-10
EP0932392A1 (en) 1999-08-04
WO1997034583A1 (en) 1997-09-25

Similar Documents

Publication Publication Date Title
AU5504996A (en) Composition for inducing a mucosal immune response
AU4289496A (en) Method of promoting an immune response with a bispecific antibody
AU2637395A (en) Method and apparatus useful for detecting bloodgroup antigens and antibodies
AU7983198A (en) Improved methods for inducing an immune response
AU5488496A (en) Fuel separator apparatus
HUP9903770A3 (en) Method and composition for reconforming multi-epitopic antigens to initiate an immune response
AU6384596A (en) An improved electrochemiluminescence method
AU3972193A (en) Method for inducing tolerance to an antigen using butyrate
HUP9801223A3 (en) Method for enhancing the antibody response to specific antigens with interleukin-10
AU7252298A (en) A method and system for simulating the solar cycle
AU5963996A (en) Patient-to-transducer interface device
AU698352B2 (en) Interface device
EP0896506A4 (en) Methods for inducing immune responsiveness in a subject
AU6820796A (en) Antigenic preparations
AU682805B1 (en) Method for inducing a systemic immune response to an antigen
GB9710820D0 (en) Immunological method
AU8016998A (en) Method for detecting hiv antibodies and antigens used to this end
EP0726463A3 (en) Method for serotyping using type-specific antigens
AU7585998A (en) Controlling immune response to specific antigens
AU6123996A (en) Device for connecting structural parts
AU8167498A (en) Method for inducing a systemic immune response to a hepatitis or hiv antigen
AU5271296A (en) Novel method
AU1239892A (en) A method for constructing antigens
AU6371396A (en) Helicobacter antigens
AU5047196A (en) Motive device